These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37872471)

  • 1. Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study.
    Kutzinski M; Krause N; Riemann-Lorenz K; Meyer B; Heesen C
    BMC Neurol; 2023 Oct; 23(1):382. PubMed ID: 37872471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a digital lifestyle management intervention (levidex) to improve quality of life in people with multiple sclerosis: results of a randomized controlled trial.
    Meyer B; Betz LT; Jacob GA; Krause N; Riemann-Lorenz K; Gold SM; Pöttgen J; Heesen C
    BMC Neurol; 2024 Sep; 24(1):347. PubMed ID: 39285343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'That would have been the perfect thing after diagnosis': development of a digital lifestyle management application in multiple sclerosis.
    Krause N; Riemann-Lorenz K; Rahn AC; Pöttgen J; Köpke S; Meyer B; Thale F; Temmes H; van de Loo M; Gold SM; Heesen C
    Ther Adv Neurol Disord; 2022; 15():17562864221118729. PubMed ID: 36092248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trial.
    Krause N; Derad C; von Glasenapp B; Riemann-Lorenz K; Temmes H; van de Loo M; Friede T; Asendorf T; Heesen C;
    Mult Scler Relat Disord; 2023 Nov; 79():105043. PubMed ID: 37839367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: a randomised controlled feasibility study.
    Carter AM; Daley AJ; Kesterton SW; Woodroofe NM; Saxton JM; Sharrack B
    Contemp Clin Trials; 2013 Jul; 35(2):40-7. PubMed ID: 23612222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
    Chruzander C; Gottberg K; Ytterberg C; Backenroth G; Fredrikson S; Widén Holmqvist L; Johansson S
    Disabil Rehabil; 2016 Dec; 38(24):2383-91. PubMed ID: 26750510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-week inpatient energy management education (IEME) for persons with multiple sclerosis-related fatigue: Feasibility of a randomized clinical trial.
    Hersche R; Weise A; Michel G; Kesselring J; Bella SD; Barbero M; Kool J
    Mult Scler Relat Disord; 2019 Oct; 35():26-33. PubMed ID: 31280074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol for an online lifestyle modification education course for people living with multiple sclerosis: the multiple sclerosis online course (MSOC).
    Reece JC; Yu M; Bevens W; Simpson-Yap S; Jelinek G; Jelinek P; Davenport R; Nag N; Gray K; Neate S
    BMC Neurol; 2023 Jun; 23(1):249. PubMed ID: 37386385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Don't be late! Postponing cognitive decline and preventing early unemployment in people with multiple sclerosis: a study protocol.
    Aarts J; Saddal SRD; Bosmans JE; de Groot V; de Jong BA; Klein M; Ruitenberg MFL; Schaafsma FG; Schippers ECF; Schoonheim MM; Uitdehaag BMJ; van der Veen S; Waskowiak PT; Widdershoven GAM; van der Hiele K; Hulst HE;
    BMC Neurol; 2024 Jan; 24(1):28. PubMed ID: 38225561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation: a randomized controlled pilot and feasibility study [ReFEx].
    Wolf F; Nielsen J; Saliger J; Hennecken E; Kröber P; Eschweiler M; Folkerts AK; Karbe H; Zimmer P
    BMC Neurol; 2023 Oct; 23(1):388. PubMed ID: 37898772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
    Neven A; Janssens D; Alders G; Wets G; Van Wijmeersch B; Feys P
    Disabil Rehabil; 2013 Sep; 35(20):1718-25. PubMed ID: 23343357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
    Carter A; Daley A; Humphreys L; Snowdon N; Woodroofe N; Petty J; Roalfe A; Tosh J; Sharrack B; Saxton JM
    Mult Scler; 2014 Jul; 20(8):1112-22. PubMed ID: 24421303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic exercise intervention for people with multiple sclerosis (ExIMS trial): study protocol for a randomised controlled trial.
    Saxton JM; Carter A; Daley AJ; Snowdon N; Woodroofe MN; Petty J; Roalfe A; Tosh J; Sharrack B
    Contemp Clin Trials; 2013 Mar; 34(2):205-11. PubMed ID: 23123791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.
    D'hooghe M; Van Gassen G; Kos D; Bouquiaux O; Cambron M; Decoo D; Lysandropoulos A; Van Wijmeersch B; Willekens B; Penner IK; Nagels G
    Mult Scler Relat Disord; 2018 May; 22():90-96. PubMed ID: 29649789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.
    Patt N; Kool J; Hersche R; Oberste M; Walzik D; Joisten N; Caminada D; Ferrara F; Gonzenbach R; Nigg CR; Kamm CP; Zimmer P; Bansi J
    BMC Neurol; 2021 Feb; 21(1):65. PubMed ID: 33573608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled pilot and feasibility study of multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation (ReFEx): study protocol.
    Wolf F; Nielsen J; Saliger J; Hennecken E; Eschweiler M; Folkerts AK; Karbe H; Zimmer P
    BMJ Open; 2022 Sep; 12(9):e062160. PubMed ID: 36357342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline engagement with healthy lifestyles and their associations with health outcomes in people with multiple sclerosis enrolled in an online multimodal lifestyle course.
    Yu M; Neate S; Nag N; Bevens W; Jelinek G; Simpson-Yap S; Davenport RA; Fidao A; Reece J
    Eur J Neurol; 2024 Oct; 31(10):e16429. PubMed ID: 39109838
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.